Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Cerebrovasc Dis. 2008;25(1-2):50-8. Epub 2007 Nov 22.

Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans.

Author information

  • 1Berlin Neuroimaging Center and Department of Neurology, CharitĂ© - University Medicine Berlin, Berlin, Germany. georg.haeusler@charite.de

Abstract

BACKGROUND:

We have recently shown that ischemic stroke causes a stress-mediator-induced long-lasting immunodepressive state in mice.

METHODS:

Using head magnetic resonance imaging and standardized immunoassays, we prospectively investigated whether poststroke immunodepression is also seen in humans.

RESULTS:

Compared to healthy volunteers (n = 30), a rapid depression of lymphocyte counts and a functional deactivation of monocytes and T helper type 1 cells was observed in acute stroke patients (SP; n = 40). Immunodepression was more pronounced in patients with severe clinical deficit or large infarction. On admission the combination of monocytic tumor necrosis factor alpha release ex vivo and the National Institute of Health Stroke Scale score were the best predictors for nosocomial infection, preferentially affecting older SP.

CONCLUSION:

Our data provide evidence for an immediate suppression of cell-mediated immune responses after ischemic stroke in humans.

(c) 2007 S. Karger AG, Basel.

PMID:
18033958
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Write to the Help Desk